WHO ICTRP trial
Impact of targeted PAH therapy on the clinical course and well-being of adults…
DRKS00035552 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00035552 |
|---|---|
| Public title | Impact of targeted PAH therapy on the clinical course and well-being of adults with congenital heart defects and pulmonary arterial hypertension |
| Scientific title | Impact of targeted PAH therapy on the clinical course and well-being of adults with congenital heart defects and pulmonary arterial hypertension |
| Primary sponsor | Deutsches Herzzentrum München, TUM Universitätsklinikum |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | adults with congenital heart defects (ACHD) and pulmonary hypertension (PAH)/pulmonary vascular disease I27 Q24;Other pulmonary heart diseases;Other congenital malformations of heart |
| Interventions | Group 1: Adults with congenital heart defects and pulmonary hypertension or pulmonary vascular disease, for a time period of 12 months, with time points of 0, 4 weeks, 12 weeks, 6 months, 12 months with a validated and standardized… |
| Registration date | Dec 16, 2024 |
| Target size | 100 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: